These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25063077)

  • 1. Enhanced cellular uptake and gene silencing activity of siRNA molecules mediated by chitosan-derivative nanocomplexes.
    Guzman-Villanueva D; El-Sherbiny IM; Vlassov AV; Herrera-Ruiz D; Smyth HD
    Int J Pharm; 2014 Oct; 473(1-2):579-90. PubMed ID: 25063077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan as a carrier for targeted delivery of small interfering RNA.
    Rudzinski WE; Aminabhavi TM
    Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
    Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
    J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
    Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
    Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
    J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells.
    Jere D; Jiang HL; Kim YK; Arote R; Choi YJ; Yun CH; Cho MH; Cho CS
    Int J Pharm; 2009 Aug; 378(1-2):194-200. PubMed ID: 19501140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of silk fibroin/oligochitosan nanoparticles for siRNA delivery.
    Shahbazi B; Taghipour M; Rahmani H; Sadrjavadi K; Fattahi A
    Colloids Surf B Biointerfaces; 2015 Dec; 136():867-77. PubMed ID: 26547314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing.
    Malmo J; Sørgård H; Vårum KM; Strand SP
    J Control Release; 2012 Mar; 158(2):261-8. PubMed ID: 22119955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
    Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
    J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.
    Ragelle H; Colombo S; Pourcelle V; Vanvarenberg K; Vandermeulen G; Bouzin C; Marchand-Brynaert J; Feron O; Foged C; Préat V
    J Control Release; 2015 Aug; 211():1-9. PubMed ID: 25989603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of ternary nanoplexes for efficient small interfering RNA delivery.
    Şalva E; Turan SÖ; Akbuğa J
    Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity.
    Guţoaia A; Schuster L; Margutti S; Laufer S; Schlosshauer B; Krastev R; Stoll D; Hartmann H
    Carbohydr Polym; 2016 Jun; 143():25-34. PubMed ID: 27083340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chitosan-siRNA complex nanoparticles for gene silencing].
    Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics.
    Martirosyan A; Olesen MJ; Howard KA
    Adv Genet; 2014; 88():325-52. PubMed ID: 25409611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain.
    Gao Y; Wang ZY; Zhang J; Zhang Y; Huo H; Wang T; Jiang T; Wang S
    Biomacromolecules; 2014 Mar; 15(3):1010-8. PubMed ID: 24547943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
    Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
    Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
    Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
    J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.